AR063330A1 - Nanoparticulas micelares incrustadas - Google Patents

Nanoparticulas micelares incrustadas

Info

Publication number
AR063330A1
AR063330A1 ARP070104595A ARP070104595A AR063330A1 AR 063330 A1 AR063330 A1 AR 063330A1 AR P070104595 A ARP070104595 A AR P070104595A AR P070104595 A ARP070104595 A AR P070104595A AR 063330 A1 AR063330 A1 AR 063330A1
Authority
AR
Argentina
Prior art keywords
embedded
micellary
nanoparticles
micelles
solid composition
Prior art date
Application number
ARP070104595A
Other languages
English (en)
Spanish (es)
Inventor
Jan P Moschwitzer
Original Assignee
Solvay Pharm Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Bv filed Critical Solvay Pharm Bv
Publication of AR063330A1 publication Critical patent/AR063330A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ARP070104595A 2006-10-20 2007-10-17 Nanoparticulas micelares incrustadas AR063330A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06122648 2006-10-20

Publications (1)

Publication Number Publication Date
AR063330A1 true AR063330A1 (es) 2009-01-21

Family

ID=37671256

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP070104595A AR063330A1 (es) 2006-10-20 2007-10-17 Nanoparticulas micelares incrustadas

Country Status (8)

Country Link
CN (2) CN101686946A (pt)
AR (1) AR063330A1 (pt)
BR (1) BRPI0719826A8 (pt)
HK (1) HK1199829A1 (pt)
MX (1) MX2009004124A (pt)
SA (1) SA07280548B1 (pt)
TW (1) TWI392507B (pt)
UA (1) UA97496C2 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI661841B (zh) * 2017-04-19 2019-06-11 三凡生技研發股份有限公司 用於分散疏水性植物萃取物之載劑
EP3424493A1 (en) * 2017-07-07 2019-01-09 SolMic Research GmbH Stable cannabinoid compositions
CN110302155B (zh) 2019-07-31 2021-09-21 江南大学 一种黄原胶共聚物纳米胶束的制备方法及其应用
CN112915121A (zh) * 2019-12-06 2021-06-08 汉义生物科技（北京）有限公司 一种大麻素纳米胶束制剂及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9700866B2 (en) * 2000-12-22 2017-07-11 Baxter International Inc. Surfactant systems for delivery of organic compounds
EP1415648B1 (en) * 2001-07-13 2006-11-22 NanoCarrier Co., Ltd. Lyophilizing composition of drug-encapsulating polymer micelle and method for preparation thereof
IL153277A0 (en) * 2002-12-04 2003-07-06 Pharmos Corp High enantiomeric purity dexanabinol for pharmaceutical compositions
WO2005118612A1 (en) * 2004-06-04 2005-12-15 Sonus Pharmaceuticals, Inc. Cholesterol/bile acid/bile acid derivative-modified therapeutic anti-cancer drugs

Also Published As

Publication number Publication date
CN101686946A (zh) 2010-03-31
UA97496C2 (ru) 2012-02-27
BRPI0719826A8 (pt) 2017-04-04
MX2009004124A (es) 2009-07-22
HK1199829A1 (en) 2015-07-24
CN104188926A (zh) 2014-12-10
TWI392507B (zh) 2013-04-11
TW200824711A (en) 2008-06-16
BRPI0719826A2 (pt) 2014-05-06
SA07280548B1 (ar) 2011-10-08

Similar Documents

Publication Publication Date Title
EA200900572A1 (ru) Мицеллярные наночастицы с химическими субстанциями
CL2009001766A1 (es) Composicion farmaceutica solida para administracion oral que comprende: un taxano sustancialmente amorfo definido, un portador hidrofilico definido y un tensoactivo definido; metodo para preparar la composicion; y su uso para tratar una enfermedad neoplasica.
TR201902233T4 (tr) Hızlı çözünen katı dozaj formu.
GT200500155A (es) Terapia del càncer resistente al platino
WO2010128504A3 (en) Nano-sized particles comprising multi-headed amphiphiles for targeted drug delivery
DK1796650T3 (da) Transport- og afgivelsesvehikel indeholdende nanopartikler
BR112013016772B8 (pt) compostos, uso do composto e composição farmacêutica
CL2011002222A1 (es) Metodo para preparar una proteina biologica condicionalmente activa; metodo para preparar un modificador condicionalmente activo de respuesta biologica.
MX2009005727A (es) Nanoparticulas de entidad anfifilica.
MX2010011564A (es) Formulaciones mejoradas para ingredientes farmaceuticos activos de permeabilidad deficiente.
CL2007002031A1 (es) Composicion farmaceutica que comprende una droga antiparasitaria insoluble en agua y un portador soluble en agua, en donde la droga se encuentra en la forma nano-dispersa; dispersion acuosa que la comprende; proceso para prepararla, util para el tratamiento o profilaxis de la malaria.
DK2054042T3 (da) Fremgangsmåder til fremstilling af biologisk aktive forbindelser i nanopartikelform
BRPI0518869A2 (pt) agentes citotàxicos compreendendo taxanos
CL2009001556A1 (es) Sistema de administración transdermica de fármacos que comprende una capa que contiene fármaco que comprende una matriz polimérica que contiene estradiol como unico fármaco; método de elaboración; útil para administrar estradiol.
MX2013000636A (es) Nanoparticulas para encapsulacion de compuestos, su obtencion y uso.
EA201200937A1 (ru) Твердая лекарственная форма тикагрелора
CL2009001080A1 (es) Procedimiento para encapsular agentes biologicamente activos en un vehiculo en forma de particulas, que comprende solubilizar en un agente de apareamiento de ion hidrofobo y un disolvente, disolver, formar la emulsion y obtener el vehiculo; vehiculo en forma de particulas; y composicion farmaceutica que comprende el vehiculo.
BRPI0912230A2 (pt) Método para encapsular agentes biologicamente ativos em um carreador particulado, carreador particulado, e, composição farmacêutica
BRPI1010550A2 (pt) formas de dosagem, e, processo para a produção de preparações para formas de dosagem de substãncias ativas fracamente solúveis e, água.
BR112012015749A2 (pt) processos para produção de um agente farmaceuticamente ativo
EA201301264A1 (ru) Способ получения неорганического материала в виде частиц
MY191875A (en) Solid dosage form
AR063330A1 (es) Nanoparticulas micelares incrustadas
UY30126A1 (es) Una nueva sal farmaceuticamente aceptable de 2-hidroxi-3-(5-(morfolin-4-ilmetil)-piridin-2-l)1h-indol-5-carbonitrilo, procedimientos para su preparacion, composiciones que la contienen yaplicaciones
CL2011002444A1 (es) Composicion farmaceutica que contiene un liposoma y el compuesto activo eribulina o su sal farmacologicamente permisible en la fase interna del liposoma; y el metodo de manufactura de la composicion de liposoma.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal